Well, it’s hard to believe it but October is here, and with it Cytokines2024! As I write this my bag is packed, my itinerary organized (sort of), and my excitement is mounting for my first trip to Seoul, Korea. The program is set, featuring Keynote speakers, Dr. Judith Allen (University [READ MORE]
My main research interest is to decipher how signals such those of the microbiota and metabolism regulate inflammatory diseases and infections of the respiratory tract. I am about to launch my independent scientific career and I am very grateful for the support of the ICIS through the Sydney and Joan [READ MORE]
The University of Pittsburgh Department of Immunology is delighted to announce three open faculty positions: one at Full/Associate Professor (tenured) and two at Assistant Professor (tenure stream). The Department of Immunology at the University of Pittsburgh School of Medicine is expanding its primary faculty base and invites applicants focused on [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers. CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus ClinicalTrials.gov ID NCT05915000 Sponsor University of Valencia Information provided by University of Valencia (Responsible Party) Last Update Posted 2023-06-22 GM-CSF for Reversal of immunopAralysis in pediatriC [READ MORE]
Meet Laura Mackay, Ph.D., Professor at The University of Melbourne and Immunology Theme Lead at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. She completed her Ph.D. in 2009 under the supervision of Professor Alan Rickinson at The University of Birmingham (UK), and postdoctoral training (2009-2015) with Professor Francis Carbone at The University of Melbourne. [READ MORE]
Contributed by Alok Pandey, Ph.D., VP Biomarker & Translational Science, PBL Assay Science When it comes to ELISA kits used for the detection of protein biomarkers, one observation we have made at PBL Assay Science—over and over again—is that not all assays are created equal. From our 30+ years of [READ MORE]
We are excited to recognize two historic milestones that resonate deeply with the International Cytokine and Interferon Society: the 50th anniversary of the term “cytokine” and the 70th anniversary of the introduction of “Interferons.” Contributed by Valeriya Smaliy and Susan Carpenter, Ph.D., University of California at Santa Cruz It was [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers. Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections ClinicalTrials.gov ID NCT06363370 Sponsor Kexing Biopharm Co., Ltd. Information provided by Kexing Biopharm Co., Ltd. (Responsible Party) Last Update Posted 2024-04-12 Mechanisms of Interferon Gamma-primed [READ MORE]
My research interests include understanding the opposing challenges faced by the immune system in response to micro- vs. macro- parasites and is studying the relationship between type 2 cytokines and IL-17 … particularly the evolutionary relationship between type 2 immunity, parasite control and tissue repair and is currently investigating how [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers. Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT ClinicalTrials.gov ID NCT06130579 Sponsor: Peking University People’s Hospital Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party) Last Update Posted 2024-03-21 MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
